Theratechnologies Inc. ("Theratechnologies" or the "Company") (TSX:TH) (NASDAQ:THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today
Cantor Fitzgerald has initiated coverage on Theratechnologies Inc (NASDAQ:THTX) with an Overweight rating and a price target of $9. Theratechnologies’ two HIV…